Jane Street’s Briacell Therapeutics BCTX Stock Holding History

Jane Street’s Portfolio BCTX Stock Details BCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85.9K	Buy	+26,515	New	+$97.6K	﹤0.01%	10679
2025 Q1	–	Sell	-198	Closed	-$16.8K	–	9422
2024 Q4	$16.8K	Buy	+198	New	+$23.7K	﹤0.01%	9148
2022 Q4	–	Sell	-647	Closed	-$546K	–	9130
2022 Q3	$546K	Buy	647 +312	+93%	+$313K	﹤0.01%	6533
2022 Q2	$290K	Buy	+335	New	+$331K	﹤0.01%	7661
2021 Q4	–	Sell	-235	Closed	-$308K	–	10052
2021 Q3	$285K	Buy	+235	New	+$216K	﹤0.01%	8286

Other funds holding BCTX

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

LCM

LuminArx Capital Management New York $224M AUM

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Jane Street's BCTX Position: Q2 2026 in Review

Jane Street opened a new position in Briacell Therapeutics (BCTX) in Q2 2026: 26,515 shares worth $85.9K. The stake represents ﹤0.01% of the portfolio and ranks #10679 among its holdings. This is a return to the name: Jane Street previously reported a position in BCTX as recently as Q4 2024.

Jane Street first reported a position in BCTX in Q3 2021 and has held it in 5 quarters since. The position peaked at $546K in Q3 2022. 19 funds tracked by Wall St. Rank hold BCTX as of Q2 2026.

Jane Street held 26,515 shares of Briacell Therapeutics worth $85.9K as of Q2 2026.
Briacell Therapeutics was a new Jane Street position in Q2 2026.
Briacell Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10679 holding.
Jane Street first reported a position in Briacell Therapeutics in Q3 2021 and has held it in 5 quarters since.
Jane Street's Briacell Therapeutics position peaked at $546K in Q3 2022.
19 funds tracked by Wall St. Rank held Briacell Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.